Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases

Purpose - To assess degradable starch microsphere (DSM) transarterial chemoembolization (TACE) retrospectively as salvage therapy in patients with unresectable uveal melanoma (UM) liver metastases and identify prognostic factors for survival. - Materials and Methods - Fifty-five patients (49.1% male...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steinberg, Hannah Luisa (VerfasserIn) , Haubold, Johannes (VerfasserIn) , Bauer, Sebastian (VerfasserIn) , Richly, Heike (VerfasserIn) , Siveke, Jens T. (VerfasserIn) , Wimmer, Julia (VerfasserIn) , Umutlu, Lale (VerfasserIn) , Schaarschmidt, Benedikt M. (VerfasserIn) , Theysohn, Jens M. (VerfasserIn) , Ludwig, Johannes Maximilian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2025
In: Journal of vascular and interventional radiology
Year: 2025, Jahrgang: 36, Heft: 9, Pages: 1418-1426.e1
ISSN:1535-7732
DOI:10.1016/j.jvir.2025.05.020
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.jvir.2025.05.020
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1051044325003811
Volltext
Verfasserangaben:Hannah L. Steinberg-Vorhoff, MD, Johannes Haubold, MD, Sebastian Bauer, MD, Heike Richly, MD, Jens T. Siveke, MD, Julia Wimmer, MD, Lale Umutlu, MD, Benedikt M. Schaarschmidt, MD, Jens M. Theysohn, MD, and Johannes M. Ludwig, MD

MARC

LEADER 00000naa a2200000 c 4500
001 194572305X
003 DE-627
005 20251210103443.0
007 cr uuu---uuuuu
008 251210s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jvir.2025.05.020  |2 doi 
035 |a (DE-627)194572305X 
035 |a (DE-599)KXP194572305X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Steinberg, Hannah Luisa  |d 1992-  |e VerfasserIn  |0 (DE-588)1278617353  |0 (DE-627)1831526859  |4 aut 
245 1 0 |a Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases  |c Hannah L. Steinberg-Vorhoff, MD, Johannes Haubold, MD, Sebastian Bauer, MD, Heike Richly, MD, Jens T. Siveke, MD, Julia Wimmer, MD, Lale Umutlu, MD, Benedikt M. Schaarschmidt, MD, Jens M. Theysohn, MD, and Johannes M. Ludwig, MD 
264 1 |c September 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 26. Mai 2025, Artikelversion: 20. August 2025 
500 |a Gesehen am 10.12.2025 
520 |a Purpose - To assess degradable starch microsphere (DSM) transarterial chemoembolization (TACE) retrospectively as salvage therapy in patients with unresectable uveal melanoma (UM) liver metastases and identify prognostic factors for survival. - Materials and Methods - Fifty-five patients (49.1% male; median age, 65 years) who underwent a median of 2 DSM-TACE treatments (range, 1-12) were included. Cox proportional hazards models for univariate analysis and multivariate analysis and Kaplan-Meier analysis were performed to determine the median overall survival (mOS) and time to progression (TTP) (95% CI). Response assessment was performed according to the Response Evaluation Criteria in Solid Tumours (RECIST) 1.1 criteria. - Results - The mOS of the study cohort was 8.0 months (95% confidence interval [CI], 6.7-9.3). Univariate analysis identified a low lactate dehydrogenase (LDH) level (<2 times the upper level of normal) (hazard ratio [HR] 0.26, 95% CI 0.12-0.57, P < .001), normal serum protein level (HR 0.32, 95% CI 0.15-0.7, P = .008), hepatic tumor burden of ≤25% (HR 0.39, 95%CI 0.19-0.78, P = .007), and monthly tumor growth rate (TGR) of ≤20% before the first DSM-TACE (HR 0.32, 95% CI 0.14-0.7, P = .005) as predictors of prolonged mOS. Multivariate analysis confirmed a low LDH level (mOS, 11.4 vs 4.3 months; P = .021) and low TGR (mOS, 9.9 vs 6.4 months; P = .005) as independent predictors. The median TTP was 4 months (95% CI, 3.1-5.7). The best response observed was partial response in 13.6%, stable disease in 65.9%, and progressive disease in 20.5%, with mOS times of 25 (95% CI, 13.5-31.6), 8.0 (95% CI, 7.1-9.8), and 4.4 (95% CI, 2.1-20.4) months, respectively. - Conclusions - DSM-TACE represents a salvage treatment option for patients with UM with liver metastases that can help control the tumor. Lower pretreatment serum LDH levels and low TGR have been associated with prolonged mOS. However, direct comparison with alternative treatments is required. 
700 1 |a Haubold, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Bauer, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Richly, Heike  |e VerfasserIn  |4 aut 
700 1 |a Siveke, Jens T.  |e VerfasserIn  |4 aut 
700 1 |a Wimmer, Julia  |e VerfasserIn  |4 aut 
700 1 |a Umutlu, Lale  |e VerfasserIn  |4 aut 
700 1 |a Schaarschmidt, Benedikt M.  |e VerfasserIn  |4 aut 
700 1 |a Theysohn, Jens M.  |e VerfasserIn  |4 aut 
700 1 |a Ludwig, Johannes Maximilian  |d 1984-  |e VerfasserIn  |0 (DE-588)1072015560  |0 (DE-627)826782949  |0 (DE-576)433484144  |4 aut 
773 0 8 |i Enthalten in  |t Journal of vascular and interventional radiology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 36(2025), 9, Seite 1418-1426.e1  |h Online-Ressource  |w (DE-627)326643524  |w (DE-600)2041331-2  |w (DE-576)094480702  |x 1535-7732  |7 nnas  |a Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases 
773 1 8 |g volume:36  |g year:2025  |g number:9  |g pages:1418-1426.e1  |g extent:10  |a Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases 
856 4 0 |u https://doi.org/10.1016/j.jvir.2025.05.020  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1051044325003811  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251210 
993 |a Article 
994 |a 2025 
998 |g 1072015560  |a Ludwig, Johannes Maximilian  |m 1072015560:Ludwig, Johannes Maximilian  |d 60000  |d 62900  |e 60000PL1072015560  |e 62900PL1072015560  |k 0/60000/  |k 1/60000/62900/  |p 10  |y j 
999 |a KXP-PPN194572305X  |e 4826034393 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases","title_sort":"Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastases"}],"person":[{"display":"Steinberg, Hannah Luisa","roleDisplay":"VerfasserIn","role":"aut","family":"Steinberg","given":"Hannah Luisa"},{"roleDisplay":"VerfasserIn","display":"Haubold, Johannes","role":"aut","family":"Haubold","given":"Johannes"},{"display":"Bauer, Sebastian","roleDisplay":"VerfasserIn","role":"aut","family":"Bauer","given":"Sebastian"},{"family":"Richly","given":"Heike","roleDisplay":"VerfasserIn","display":"Richly, Heike","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Siveke, Jens T.","role":"aut","family":"Siveke","given":"Jens T."},{"display":"Wimmer, Julia","roleDisplay":"VerfasserIn","role":"aut","family":"Wimmer","given":"Julia"},{"roleDisplay":"VerfasserIn","display":"Umutlu, Lale","role":"aut","family":"Umutlu","given":"Lale"},{"display":"Schaarschmidt, Benedikt M.","roleDisplay":"VerfasserIn","role":"aut","family":"Schaarschmidt","given":"Benedikt M."},{"roleDisplay":"VerfasserIn","display":"Theysohn, Jens M.","role":"aut","family":"Theysohn","given":"Jens M."},{"role":"aut","display":"Ludwig, Johannes Maximilian","roleDisplay":"VerfasserIn","given":"Johannes Maximilian","family":"Ludwig"}],"recId":"194572305X","language":["eng"],"note":["Online verfügbar: 26. Mai 2025, Artikelversion: 20. August 2025","Gesehen am 10.12.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["194572305X"],"doi":["10.1016/j.jvir.2025.05.020"]},"origin":[{"dateIssuedDisp":"September 2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Hannah L. Steinberg-Vorhoff, MD, Johannes Haubold, MD, Sebastian Bauer, MD, Heike Richly, MD, Jens T. Siveke, MD, Julia Wimmer, MD, Lale Umutlu, MD, Benedikt M. Schaarschmidt, MD, Jens M. Theysohn, MD, and Johannes M. Ludwig, MD"]},"relHost":[{"id":{"eki":["326643524"],"zdb":["2041331-2"],"issn":["1535-7732"]},"origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier ; Lippincott Williams & Wilkins","dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Hagerstown, Md."}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of vascular and interventional radiology","subtitle":"JVIR ; official journal of the Society of Cardiovascular and Interventional Radiology","title_sort":"Journal of vascular and interventional radiology"}],"recId":"326643524","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Degradable starch microsphere transarterial chemoembolization as salvage therapy in patients with uveal melanoma liver metastasesJournal of vascular and interventional radiology","note":["Gesehen am 06.09.13"],"titleAlt":[{"title":"JVIR"}],"part":{"extent":"10","volume":"36","text":"36(2025), 9, Seite 1418-1426.e1","pages":"1418-1426.e1","issue":"9","year":"2025"},"pubHistory":["1.1990 -"]}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}]} 
SRT |a STEINBERGHDEGRADABLE2025